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Regulatory proteinTo characterise the pattern of the transcriptional regulation of equine herpesvirus type 1 (EHV-1)
UL24 by regulatory proteins, we identiﬁed two distinct promoter regions and two transcription ini-
tiation (Tci) sites located upstream of the UL24 open reading frame (ORF). The ORF proximal pro-
moter exhibited higher cis-activity than that of the distal one. Contrary to the former, the latter
performed its function dependent on an initiator (INR) due to its lack of a TATA box. Our results
showed that the EHV-1 regulatory proteins EICP0, EICP22 and ETIF trans-activated the two promot-
ers, whereas IEP and IR2P displayed negative regulation. In summary, the regulatory proteins exhib-
ited similar regulatory patterns for the two distinct promoters of EHV-1 UL24.
 2015 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
EHV-1 is capable of causing a respiratory disease (rhinopneu-
monitis) and nervous system damage (myeloencephalopathy) in
horses worldwide. Affected equines show a variety of clinical
symptoms, including anorexia, fever, ocular discharge, nasal dis-
charge, ataxia of varying severity, paralysis, abortion and neonatal
foal death [1,2]. EHV-1 serves as a model for studying aspects of
alpha herpesviruses, such as productive and persistent infection,
gene regulation and immune responses against these infections
with members of this subfamily [3–11]. The genome of EHV-1
harbours at least 76 genes [12,13], including one known as UL24.
This gene is evolutionarily conserved among many members of
the family Herpesviridae and is considered as a core gene for
herpesviruses [14–16]. The UL24 of herpes simplex virus 1
(HSV-1) exerts some effects on the sub-cellular distribution of viral
glycoproteins associated with fusion [17]. It plays an important
role in dispersing nucleolin [18]. In addition, it is associated withnervous pathogenicity [19–21]. Transcriptional regulation
performs an important role in the pathogenicity of herpesviruses
as well as in keeping a cascaded expression of viral genes in the
temporal order of immediate-early (a), early (b) and late (c) upon
viral infection [22–24]. The late pattern is further divided into two
types: leaky-late (c1), whose expression begins prior to viral
genome replication and subsequently reaches maximal levels after
the onset of viral DNA replication and true-late (c2), whose expres-
sion is strictly dependent on replication of the viral genome [25].
The temporal expression of EHV-1 genes is manipulated in a
coordinated fashion by seven molecules: an immediate-early (IE)
protein, four early proteins (EICP0, EICP22, EICP27 and IR2P), a late
ETIF protein and a late IR3 RNA. The IE protein trans-activates EHV-1
promoters via binding to 50-ATCGT-30 (as a consensus sequence)
located in promoters by recruiting more TATA-binding proteins
(TBP) and transcriptional factor IIB (TFIIB) to facilitate the forma-
tion of the transcription initiation complex [5,7]. IR2P acts as a neg-
ative factor to downregulate promoter cis-activity by squelching
the supplies of limited cellular factors, resulting in dramatically
reduced levels of gene expression and viral titres [26,27]. ETIF, a
tegument protein, trans-activates only the IE promoter by forming
complexes with transcription factor Oct-1 that binds to octamer
sequences [28,29]. EICP0 independently trans-activates all classes
of EHV-1 gene promoters by binding to TBP and TFIIB [25,30]. IR3,
the RNA antisense to the IE gene, is poorly translated into protein
[31]. The biological function of IR3 during EHV-1 infection remains
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trans-activate promoters. They cooperate synergistically to stimu-
late the IE gene promoter and together function as co-factors to
enhance the activity of IE. EICP27 acts together with EICP0 to
trans-activate early and leaky-late promoters. Also, EICP27 inter-
acts directly with TBP. However, EICP22 and EICP0 do not function
synergistically to affect any EHV-1 promoters [10,33,34].
The thymidine kinase gene (TK) in Herpesviridae overlaps the
promoter of neighbouring UL24 on the complementary strand.
This genomic range is consistently conserved in many her-
pesviruses [16,35,36]; for instance, in human herpesvirus 1 (HHV-
1), also called HSV-1. The UL24 of HSV-1 transcripts that contain
the entire open reading frame (ORF) are derived from two transcrip-
tion initiation (Tci) sites. Another initiation site is present within
the ORF, which may yield speciﬁc mRNA required for translating
a truncated form of this protein. These transcripts fall into two
groups, dependent on two distinct polyadenylation (polyA) sites;
one site is located downstream of the UL24 termination codon
and the other is present downstream of the UL26 ORF [14,37,38].
The UL24 polyA site-utilising transcripts exhibit early kinetics (b)
and those utilising the UL26 polyA site exhibit leaky-late kinetics
(c1) [14]. The kinetics of HSV-1 UL24 expression can be regulated
at a posttranscriptional level by alternative polyadenylation stimu-
lated by HSV-1 ICP27 (an EICP27 homologue) [37,38]. Therefore,
UL24 is considered as a potential model for elucidating ICP27 func-
tion. This may apply to the temporal regulation of EHV-1 UL24
expression in consideration of the close genetic relationship
between EHV-1 and HSV-1. The sequence identity between EHV-1
and HSV-1 is 48.4% (nucleotide) or 35.2% (amino acid) upon deter-
mined by Clustal W alignment. However, both the promoter region
and transcriptional regulation by regulatory proteins are unknown
for EHV-1 UL24 as well as for the HSV-1 homologue. Moreover, it is
generally accepted that the key determinants of gene expression
kinetics are the differences in transcriptional regulation resulting
from variations in promoter architecture.2. Materials and methods
2.1. Cell culture, EHV-1 growth and titration
Rabbit kidney cells (RK13) were purchased from the American
Type Culture Collection (ATCC) and cultured them in Dulbecco’s
modiﬁed Eagle’s medium supplemented with 10% foetal bovine
serum (FBS), 100 units/ml penicillin and 100 lg/ml streptomycin
at 37 C with 5% CO2. The 438/77 strain of EHV-1 were obtained
from ATCC and propagated in the RK13 cells and performed the
plaque assays to titre EHV-1 as previously described [39].
2.2. 50 Rapid ampliﬁcation of cDNA ends (RACE)
The total RNA from RK13 cells infected with EHV-1 at 2 multi-
plicity of infection (m.o.i) was obtained by using an RNA
Puriﬁcation Kit (Fermentas) according to manufacturer’s instruc-
tions. The 50RACE was performed using the 50-Full RACE Kit
(TAKARA) and the following UL24-speciﬁc primers: UL24 Outer
primer and UL24 Inner primer; the primers for adaptor were
50RACE outer primer and 50RACE inner primer (Fig. 1A). The
50RACE polymerase chain reaction (PCR) products were inserted
into the pMD18-T cloning vector (TAKARA) and sequenced it using
RV-M and M13-47 primers.
2.3. PCR and plasmids
All primers used to obtain the UL24 promoter regions are listed
in Table 1, and KpnI and Bgl II are both underlined and italicised.The genomic DNA of EHV-1 was prepared according to the Viral
DNA Kit (Omega) instructions. We designed two primer pairs to
amplify UL24I and UL24II-1 using genomic DNA as a template. To
obtain UL24II-2, -3, -4, -5, -6, -7 and -8 (Fig. 2A), we designed a ser-
ies of different reverse primers and intermediate primers for its
respective PCR round using UL24II-1 as a template. The mutation
and deletion of GC box, TATA box and INR in UL24I and UL24II-5
was achieved by sequence overlapping extension (SOE) PCR using
aided primers without a TATA box or INR or with mutated GC
box, TATA box and INR (Table 1). All the PCR products were puri-
ﬁed by using a Gel Extraction Kit (Omega), and digested them with
endonucleases KpnI and Bgl II followed by a second gel puriﬁcation
for downstream assays.
We previously constructed the effector plasmids expressing
regulatory proteins in our lab. We inserted the prepared PCR prod-
ucts for the UL24 promoter regions into pGL3-Basic (Clon-tech) to
produce ﬁreﬂy luciferase reporter plasmids. We conﬁrmed all
recombinant plasmids by DNA sequencing before the follow-up
experiments.
2.4. Transfection
RK-13 cells were plated within 24 h prior to transfection and
cultured to a monolayer cell density of 80% conﬂuency in 6- or
24-well plates. The fresh DMEM containing 10% FBS were added
into the culture wells. The transfection reagent, PolyJet
(Signagen), and plasmids were diluted with serum-free DMEM
and high glucose, respectively. The diluted PolyJet was immedi-
ately added to the diluted DNA solution all at once followed by
immediately mixing and vortexing brieﬂy, and let transfection
complex formed at room temperature for 15 min and added onto
added drop-wise onto the media and homogenised by swirling
gently. To reduce cytotoxicity, the media containing transfection
complex were replaced with fresh DMEM containing 10% FBS 6 h
post transfection.
2.5. Western blot
In our lab, we previously cloned the HA-tagged IEP, IR2P, EICP0,
EICP22, EICP27 and ETIF genes into pEF4/myc-His B (Invitrogen) to
generate a series of effector plasmids, namely: pIE, pIR2, pEICP0,
pEICP22, pEICP27, and pETIF. Western blot was performed exactly
as described previously. Proteins from RK13 cells transfected with
the above plasmids were isolated in RIPA buffer, separated by SDS–
PAGE, and then electro-transferred onto nylon membranes.
Subsequently, the membranes were blocked in the TBS containing
5% skimmed milk for 2 h at room temperature, and incubated with
the diluted anti-HA tag mouse monoclonal antibody (mAb) and
anti-b-actin mouse polyclonal antibody (Sigma) in the 5% skimmed
milk for 2 h. Membranes were rinsed three times using TBS con-
taining 0.05% Tween 20 (TBST) and incubated with Alexa Fluor
800-conjuated goat anti-mouse IgG (Odyssey) secondary antibody
for 1 h at room temperature. Target proteins were detected by
using the Odyssey system (Li-Cor) follow ing a second round of
TBST rinsing.
2.6. Luciferase reporter assay
We performed the luciferase reporter assays for detecting UL24
promoter regions with slight modiﬁcation as previously described
[40]. Brieﬂy, RK13 cells cultured in 24-well were transfected with
0.5 lg of a series of reporter plasmids, a negative control (pGL3-
Basic) and a positive control (pGL3-Control) together with
0.05 lg of an internal control plasmid pRL-TK expressing a renilla
luciferase. The luciferase activities were determined using a dual-
luciferase reporter assay system (Promega) and a luminometer
Fig. 1. A schematic map of 50RACE ampliﬁcation and the EHV-1 UL24 transcription initiation site. (A). Total RNA was obtained from RK13 cells infected with EHV-1 at 6 hpi.
The adaptor was fused to the 50 terminal end of the mRNA in the presence of T4 RNA ligase after removing the 50phosphate groups by CIAP, and the 50cap structure by TAP. At
the bottom of this panel, the twill rectangle represents the 50 untranslated region (50UTR) between the adaptor and the UL24 ORF. The number above the black rectangle
indicates the 50terminal base locus of the outer and inner primers in the EHV-1 Ab4 genome (Genebank: AY665713). RT, reverse transcription; (B) at the top of this panel, the
numbers represent the respective loci of the initiation codon ATG, stop codon TAG and the polyA sites of the UL24 and TK in the EHV-1 genome. The bottom part shows that
the inner PCR products were stained with ethidium bromide in a 1.2% agarose gel. The numbers ﬂanking this image indicate the corresponding loci of Tci1 (lower band) and
Tci 2 (upper band) in the EHV-1 genome. The other faint bands were not derived from the EHV-1 genome but from RK13 cells upon DNA sequencing and BLAST analysis.
Y. Ma et al. / FEBS Letters 589 (2015) 1467–1475 1469(Berthold). The relative ﬁreﬂy luciferase activity was normalised to
renilla luciferase activity in each assay. Each test was repeated in
triplicates in one independent experiment, which was performed
three times.
To characterise the regulation pattern of EHV-1 regulatory pro-
teins upon UL24 promoter regions, RK13 cells were co-transfected
with 0.3 pmol of promoter reporter plasmids and 0.3 pmol of effec-
tor plasmids or empty vectors. The total amount of DNA per trans-
fection was adjusted to 6 lg by the addition of pEF4/myc-His B. To
exclude the possibility of regulatory proteins affecting SV40 pro-
moter cis-activity, we normalised the ﬁreﬂy luciferase activity;
did not use pRL-TK but instead altered the protein concentration
of cell lysates as previously described [41].
3. Results
3.1. Two distinct initiation sites of UL24 transcription
To analyse the transcription initiation sites located upstream of
the UL24 translation start site (ATG), we performed 50RACE assay
using the total RNA of RK13 cells infected with EHV-1 438/77strain at 8 hpi. The ﬁrst round of ampliﬁcation was run by using
the outer primer pair. No bands were visible after the ﬁrst ampli-
cation round. The product of the ﬁrst round of PCR (1 ll) was used
as a template to perform the second round of ampliﬁcation round
with the inner primer pair (Fig. 1A). As shown in the lower panel of
Fig. 1B, PCR products were identiﬁed using 1.2% agarose gel stained
with ethidium bromide. No PCR products were obtained from the
parallel reactions free reverse transcriptase or when we used water
as a template (data not shown), which showed that the PCR
products were derived from RNA. Approximately 15–20 clones
from each 50RACE product were sequenced and conﬁrmed to
harbour identical 50 ends, which indicated that they were derived
from a single UL24 mRNA species. The preliminary assay showed
the presence of two positive bands of 500 bp and 200 bp as well
as several interfering DNA bands in the PCR products (Fig. 1B).
However, the nature of these interfering bands was unclear,
and their sequence data was not signiﬁcantly similar to the
published EHV-1 sequence. Upon sequence alignment, we
identiﬁed two distinct transcription initiation sites (Fig. 1B, upper
panel) located at 70118 nt (Tci 1) and 70 397 nt (Tci 2) of the
EHV-1 genome.
Table 1
Primers required for amplifying UL24 promoter regions.
a The primers appended with letter ‘‘F’’ or ‘‘R’’ were used to obtain the end-product of target DNA sequence, F: forward, R:
reverse; the oligos with letter ‘‘U’’ or ‘‘L’’ were adopted to amplify the intermediate product for SOE PCR, U: upper, L:
lower. UL24 Outer and Inner primer was designed based on EHV-1 Ab4 strain genome. 50RACE Outer and Inner primer
was provided in the 50RACE kit.
b The underlined 6 nucleotides represented Kpn I (GGTACC) and Bgl II (AGATCT) sites. The boxed nucleotides were the
mutated sites in the TATA box, INR and GC box of UL24I and UL24II-5.
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To identify the promoter regions of EHV-1 UL24, we designed a
series of primers to obtain six DNA fragments upstream of UL24
using genomic DNA as a template (Table 1). Each promoter region
was mapped based on an individual Tci (+1) position (Fig. 2A). In
these chosen promoter regions, the 30 ﬂanking sequence down-
stream of the Tci did not contain ATG to avoid interfering with luci-
ferase gene translation. In order to evaluate the putative promoter
cis-activity of these regions, a set of luciferase reporter plasmids
were engineered by cloning the above fragments into pGL3-Basic
(promoter- and enhancer-less) as well as itself as negative control.
Each reporter plasmid was transiently transfected into RK13 cells
together with the internal control plasmid pLR-TK. Fireﬂy lucifer-
ase activity was used to assess putative promoter activity accord-
ing to the dual luciferase reporter protocol instructions. As
shown in Fig. 2B, maximal activity was observed 48 h post-trans-
fection in RK13 cells transfected with reporter plasmid containing
UL24I. As compared with the negative control, UL24II-1 and UL24II-
5 showed higher activity, with the highest activity in the former. In
contrast, UL24II-2, UL24II-3 and UL24II-4 had lower activity than
UL24II-1 or UL24II-5 and displayed the same activity level as nega-
tive control yet. Meantime, UL24II-7 displayed higher activity thanUL24II-1, UL24II-5, UL24II-6 and UL24II-8. UL24II-5 and UL24II-7 had
a promoter activity and can be downregulated by the fragment
located between them; UL24II-8, a fusion fragment of UL24II-5
and UL24II-7, did not exhibited higher level than each one but just
as did the negative control (Fig. 2C). These ﬁndings indicated that
UL24I and UL24II-5 are responsible for UL24 transcription initiation
at Tci 1 and Tci 2, respectively.
3.3. Functional initiator, TATA box and GC box in the UL24 promoter
We identiﬁed two fragments upstream of the UL24 translation
start site as promoters. Upon common location of TATA box, initia-
tor (INR) [42] and GC box [43] in the promoter region combined
with computational analysis [44], a putative TATA box and GC
box were located 24 nt and 107 nt upstream of Tci 1 and a putative
INR was obtained from Tci 2 as well as GC box at +110 (Fig. 3A
upper panel). The HSV-1 UL24 Tcis were identiﬁed in HSV-1 strain
17 genome: 47402 nt and 47666 nt [14]. To evaluate how con-
served the initiation sites and relevant motifs are between EHV-1
and HSV-1, we selected EHV-1 70536–70048 nt covering two
Tcis and cis-elements) and HSV-1 47272–47736 nt followed by
sequence comparison. It is little known on HSV-1 UL24 promoter
region as well as relevant cis-elements. Thus, its GC box, TATA
Fig. 2. Identiﬁcation of the UL24 promoter region using a luciferase activity reporter assay. (A) Each transcription site was set as +1, Tci 1 (red triangle) and Tci 2 (green
triangle). Each DNA fragment was obtained using PCR with the primers listed in Table 1. (B) The UL24I, UL24II-1 and UL24II-5 exhibited promoter activity comparing with the
negative control (pGL3-Basic) in the following order: UL24I > UL24II-1 > UL24II-5, but UL24II-2, 3 and 4 did not. As expected, the positive control (pGL3-Control) displayed the
highest luciferase activity. (C) The promoter activity appeared in the order: UL24II-7 > UL24II-1 > UL24II-5 > UL24II-6 > UL24II-8 (similar to pGL3-Basic). The UL24II-8 was
constituted of UL24II-5 and UL24II-7. The ﬁreﬂy luciferase activity was normalised to renilla luciferase activity as an internal control. One representative of three performed
experiments is presented [mean ± standard deviation (S.D.)].
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was observed that their loci and nucleotides in promoter region
were almost one-to-one correspondence between EHV-1 UL24 pro-
moter and HSV-1 UL24 promoter regions (Fig. 3A lower panel). To
determine whether the GC box, TATA box and INR were contribut-
ing to the UL24I and UL24II-5 promoter activity, we deleted or
mutated these cis-acting elements using UL24I and UL24II-5 with
primers (Table 1). As shown in Fig. 3B and C, the mutation or dele-
tion of the TATA box (UL24ID TATA and UL24I.M.TATA), INR
(UL24II-5D INR and UL24II-5.M.INR), and GC box (UL24I.M.GC and
UL24II-5.M.GC) reduced ﬁreﬂy luciferase activity, respectively,
indicating that UL24 promoters have the functional TATA box,
INR and GC box and are indispensable to promoter activity in
RK13 cells.
3.4. Distinct regulation of UL24 promoters
The ectopic expression of six regulatory proteins was shown by
Western blot analysis at 48 h post-transfection into RK13 cells
(Fig. 4A). To characterise regulation of the UL24 promoters by the
EHV-1 regulatory proteins IEP, IR2P, EICP0, EICP22, EICP27, and
ETIF, luciferase assays were performed with a set of regulatory pro-
tein expression plasmids. As shown in Fig. 4B, EICP22 increased
UL24I and UL24II-5 promoter activity by 2.4-fold and 6-fold,
respectively, as compared with luciferase activity achieved in
RK13 cells co-transfected with empty vector. Moreover, under
the same conditions, EICP0 increased UL24I and UL24II-5 promoter
activity by 2.3-fold and 17.5-fold, respectively; ETIF also did it by
1.8-fold and 4-fold, respectively. In contrast, IR2P reduced UL24I
and UL24II-5 promoter activity by 43.4-fold and 26.3-fold, respec-
tively; IEP also reduced promoter activity by 2.3-fold and 3.9-fold,respectively. EICP27 regulated UL24I and UL24II-5 promoter activ-
ity by <1.49 fold, which was considered an extremely small effect.
These results showed that EHV-1 regulatory proteins had different
effects on UL24I and UL24II-5 promoter activity and that UL24II-5 is
more sensitive than UL24I to regulation exerted by regulatory pro-
teins except for EICP27. Moreover, UL24II-1, UL24II-2, UL24II-3,
UL24II-4 and UL24II-5 exhibited nearly same regulatory pattern
exerted by regulatory proteins.
4. Discussion
In this study, we identiﬁed the exact two promoter regions
required for EHV-1 UL24 transcription at two distinct Tci sites
located upstream of the UL24 ORF. Our results showed that the
regulatory patterns of six EHV-1 regulatory proteins for the two
promoters were very similar. EICP22, EICP0 and ETIF played a pos-
itive role, whereas IEP and IR2P played a negative role. EICP27 did
not play any part in this context. This information might provide
references for further investigation of transcriptional regulation
of UL24 homologues of the Herpesviridae family.
As shown in Fig. 2B and C, UL24II-7 displayed higher activity
than UL24II-1 and UL24II-6, and UL24II-5 did so than UL24II-2, 3,
4. This result suggested that the sequence range from 1500 and
366 nt upstream of Tci 2 functioned as a negative element and
exerted negative regulatory effect on UL24II-5 and UL24II-7 pro-
moter activity. UL24II-2, 3, 4 containing this negative sequence just
only displayed the similar activity to negative control. However,
UL24II-6 possessed superior capability to negative control even
overlapping this negative element. The UL24II-8 constituted of
UL24II-5 and UL24II-7 just displayed the negative control level,
which demonstrated that UL24II-7 did not directly assist UL24II-5
Fig. 3. The functional TATA box, INR and GC box in the UL24 promoter region. (A) The TATA box, INR GC box and Oct-1 site were predicted and analysed by GPMiner [44] or
JASPAR [57] combined with published references [28,29,42,43]. Upper panel: These cis-elements, start codon ATG of UL24 and its complement format CAT of TK were
underlined in the upstream sequence of the UL24. The transcription initiation sites were detected by 50RACE and marked with red letter and indicated as Tci (transcription
initiation site); lower panel: HSV-1 UL24 Tcis was represent ed as red letter and reported in the reference [14]; the sequence comparison between EHV-1(70536–70048 nt)
and HSV-1 (47272–47736 nt) were performed with MegAlign. (B) UL24I mutants represented by UL24I.D.TATA (deleted TATA box), UL24I.M.TATA (mutated TATA box) and
UL24I.M.GC (mutated GC box) were shown in the upper panel. These mutants displayed lower activity than UL24I in the lower panel. (C) UL24II-5 mutants represented by
UL24II-5.D.TATA (deleted TATA box), UL24II-5.M.TATA (mutated TATA box) and UL24II-5M.GC (mutated GC box) were shown in the upper panel. These mutants displayed
lower activity than UL24II-5 in the lower panel. The ﬁreﬂy luciferase activity was normalised to renilla luciferase activity as an internal control. One representative of three
performed experiments is presented (mean ± S.D.).
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was capable of counteracting the inhibitory effects of the negative
sequence and indirectly aiding UL24II-5 to ensure UL24 transcrip-
tion from Tci 2. Therefore, it could be hypothesised that UL24II-7
would generate a novel transcript possibly in term of upon pro-
moter activity. In the future research, more work needs to be con-
ducted on detecting the novel transcript and its function, and the
exact mechanism underlying that UL24II-7 performs remote regu-
lation on UL24II-5 promoter activity.
Robertson and Whalley analysed the same genome context
sequence (UL24/TK) of EHV-1, comparing the EHV-1 TK with that
of HSV-1 and other herpesviruses and assigned putative core cis-
elements in TK promoter. Furthermore, it was proposed that the
functional veriﬁcation should be required to identify the potential
TATA box determining the Tci of TK transcript [45]. Therefore, to
better explore molecular data as well as ﬁgure out possible UL24
promoter structures, we adopted the bioinformatics and referred
to the relevant literature and data to predict the TATA box, GC
box and INR, followed by functional identiﬁcation based on site-directed mutation and deletion. GC box has a consensus sequence
GGGCGG and performs function based on its position in the pro-
moter region but is not orientation independent. Usually, it is
located in the sequence upstream of the TATA box and approxi-
mately 110 bases upstream from the transcription initiation site.
The GC elements are bound by transcription factors and have sim-
ilar functions to enhancers [43]. The mutated or absent GC box can
evidently downregulate UL24I and UL24II-5 as well as the mutated
or absent TATA box and INR do so (Fig. 3B and C). Thus, the GC box,
TATA box and INR are functional for initiating UL24 transcription.
Pearson and Coen reported that the transcription start sites of
HSV-1 UL24 is 47402 nt and 47666 nt of HSV-1 strain 17 genome
[14]. In this study, the GC box, TATA box and INR in HSV-1 UL24
promoter were predicted and compared with EHV-1 counterparts
(Fig. 3A lower panel). It has been observed that their loci and
nucleotides in promoter region are almost one-to-one correspon-
dence. However, it remains unknown whether or not the HSV-1
UL24 promoter has a similar regulatory pattern to EHV-1
counterpart.
Fig. 4. The regulatory effects of the EHV-1 regulatory proteins on the UL24 promoter regions. (A) All six proteins were expressed in RK13 cells and detected by Western
blotting. (B) EICP0, EICP22 and ETIF trans-activated UL24I and UL24II-5; IEP and IR2P inhibited these two promoters’ activity; EICP27 had hardly any effects on UL24I and
UL24II-5. UL24II-1, 2, 3 and 4 presented the same pattern as UL24II-5 under regulation exerted by EHV-1 regulatory proteins. Fireﬂy luciferase activity was normalised to the
protein concentration of the cell lysates as described previously [41]. The luciferase activities are presented as means ± S.D. of three replicates per treatment in one assay of
three independent experiments.
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prerequisite for adequate translation and subsequent functions in
the life cycle of a virus. This may be particularly important for
EHV-1 and all the Herpesvirales during infection and/or replication
in vivo and in vitro. This is due to the huge size of the herpesvirus
genome as well as the fact that it harbours overlapping genes such
as IE/IR2 [26,27], IE/IR3 [31], UL24/TK [35], UL26.5/UL26 [12],
UL49.5/UL50 [46], ICP18.5/gB [47] and LAT/ICP0 [48,49]. The tran-
scription and expression of herpesvirus genes occurs in an ordered
fashion of three cascaded stages: immediate-early, early and late.
Regulatory proteins control these stages, which may be a strategy
to ensure that herpesviruses utilise the hosts’ resources most efﬁ-
ciently and overcome physical constraint among contiguous genes
and overlapping genes in their genomes of a limited size.
Dual- or triple-initiation of transcription may be another com-
plicated approach taken by herperviruses, represented by UL24
[14,50], ICP22 [51] and ICP27 [52]. There was detailed information
about the transcription start sites, promoter regions and transcrip-
tional regulation of the latter two. However, it is not known why
herpesviruses endow them with two transcription start sites
located upstream of their respective ORF. In this study, we focused
on the transcriptional regulation of UL24mainly due to the follow-
ing perspectives: (i) it is highly conserved throughout the whole
Herpesvirales; (ii) its transcription frequency is closely related with
TK transcription; (iii) UL24 is an important virulence determinant
associated with neuropathogenicity; (iv) there was previously no
information about the UL24 transcription start sites, promoters or
transcriptional regulation of most herpesvirus.
Six EHV-1 regulatory proteins were successfully expressed in
RK13 cell (Fig. 4A). Although the immunoreactive bands exhibited
the higher molecular weights than theoretical value (EHV-1 Ab4
strain: IEP, 155kDa; IR2P, 124kDa; EICP0, 59kDa; EICP22, 32kDa;
EICP27, 51kDa; ETIF, 54kDa), the similar results were also reported
in previous studies [53–55]. This could be likely due to post-trans-
lational modiﬁcation such as phosphorylation and/or glycosylation
mentioned in these references. Another possibility is that these
regulatory proteins could be associated with transcriptional factors
via protein–protein interaction.
Previous studies reported that the regulatory protein ICP27
played an important role in post-transcriptional regulation and
participated in switching from the proximal to distal polyadenyla-
tion site at the 30-end of the UL26 ORF [36,37]. This resulted in
UL24 expression throughout early and late times post-infection
[38]. Our results showed that ICP27 does not affect UL24 promoter
cis-activity, i.e., it performs no regulatory function on the transcrip-
tion initiation of UL24. As expected, IE does not trans-activate the
two promoters because there are no IEP-binding sites consensus
sequences (50-ATCGT-30) properly located near the transcription
initiation sites. In this context, IEP acts more like a negative factor
similar to IR2P; however, its impact is signiﬁcantly lower on the
latter. IR2P serves as a negative regulator that squelches the lim-
ited amount of transcriptional factors required for gene transcrip-
tion. Intracellular overexpression of IR2P dramatically reduces viral
titres in infected cells [26,27]. In this study, EICP0 independently
trans-activated UL24I promoter activity, consistent with previous
ﬁndings that EICP0 activates all classes of EHV-1 promoters har-
bouring a small promoter region containing only a TATA box and
cap site [11,30]. This is because EICP0 speciﬁcally interacts directly
with the basal transcription factors TBP and TFIIB. Even if UL24II-5
lacks a TATA box, it harbours INR that can recruit TBP-associated
factors (TAFs) [56] and directly interacts with TBP subsequently
forming protein–protein interactions with TFIIB. This may explain
why EICP0 independently upregulates UL24II-5 promoter activity
in the absence of TATA box.
Our results showed that EICP22 can increase the cis-activity of
the two promoters of the UL24 by 2.4-fold and 6-fold. However,EICP22 did not perform the normal functions of an accessory reg-
ulatory protein for EICP27 and IE (unpublished data). It may be
because neither UL24I nor UL24II-5 is an immediate early promoter
and IE cannot trans-activate these two promoters. Moreover, we
have conﬁrmed that EICP22 cannot interact with TBP directly
(unpublished data). The functions of EICP22 remain to be studied
further. Thus, UL24 should serve as a helpful model to elucidate
EICP22 functions with novel insights. ETIF can upregulate UL24I
and UL24II-5 by 1.8-fold and 4-fold, respectively. However, we
did not ﬁnd regulatory octamer sites (TAATGARAT) within the
two promoters or other octamer sequences by computational anal-
ysis [57]. One possibility is that ETIF requires another mechanism
to trans-activate the two promoters rather than forming a complex
with Oct-1.
We conclude that EHV-1 UL24 transcription begins at two start
sites upstream of the UL24 ORF subject to being driven by two dis-
tinct promoters. The UL24 ORF-proximal promoter has much more
cis-activity than the distal one. Six regulatory proteins exert similar
regulation effects on these two promoters. This suggests that the
UL24 promoter architecture would play a leading role in causing
the difference of transcription initiation frequencies from two dis-
tinct Tci under the same regulatory conditions. Meanwhile, it is
unknown whether or not the two sites for transcription initiation
switch mechanically during the EHV-1 life cycle. However, the
complicated kinetics of UL24 mRNA accumulation and its tran-
scriptional proﬁle during EHV-1 infection makes it difﬁcult to
directly answer this question.
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